CCND1 and melanoma: Ginkgetin therapy also reduced the expression of survivin, and cyclin D1, which are also ER targets.124 Epigallocatechin gallate (123) inhibited cell proliferation by reducing the PCNA protein level and promoted apoptosis in melanoma by assessed cleavage of PARP, TUNEL assay.